Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
e-Letters: Comments and Responses

Response to Comment on Scholtens et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism. Diabetes Care 2019;42:381–392

  1. Denise M. Scholtens and
  2. Boyd E. Metzger⇑
  1. Northwestern University Feinberg School of Medicine, Chicago, IL
  1. Corresponding author: Boyd E. Metzger, bem{at}northwestern.edu
Diabetes Care 2019 Jul; 42(7): e128-e129. https://doi.org/10.2337/dci19-0024
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

As described in our article (1), the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study and HAPO Follow-up Study (HAPO FUS) allowed examination of associations between maternal glucose levels during a 75-g oral glucose tolerance test (OGTT) at ∼28 weeks’ gestation, across the continuum, with child glucose metabolism at ages 10–14 years. The comment by Hulman (2) on our article (1) raises questions about exploratory trajectory analyses that complemented main regression analyses of these secondary predictors and outcomes.

First, regarding exploration of a cubic model, after the fasting blood draw, the HAPO protocol specified recording the number of minutes following glucose consumption for two subsequent blood draws: times ranged 50–70 min and 110–130 min. Using times in minutes as reported, cubic fits were explored, along with linear and quadratic models that included both fixed and random effects. Cubic models in general did not converge and thus were not reported.

Second, regarding the reported quadratic models, the comment (2) and additional reports (3) describe a rise in glucose during a 2-h OGTT, followed by a decline. It is therefore surprising that reporting a quadratic fit, given the available data, would be considered problematic (2); certainly linearity would not suffice and cubic models did not converge. Model fit criteria (4,5) identified the reported quadratic model as the best fit, given those explored for the available HAPO data. We agree with Hulman (2) that four or more time points could facilitate more accurate polynomial or spline fits.

Third, Hulman (2) states that further investigation of clinical relevance of glucose response patterns is required before changing current guidelines. Perhaps our conclusion was misunderstood; we are not advocating immediate change in current guidelines based on exploratory trajectory analyses using limited time points in HAPO data. Rather, we pointed out that the pattern of maternal glucose response, in conjunction with individual analyses of fasting, 1-h, and 2-h maternal glucose values, indicate that the full range, and likely fluctuation, of maternal glucose measures are associated with offspring metabolic outcomes.

Fourth, regarding the direct comparison of child impaired glucose tolerance for trajectory groups B and C, this would certainly be straightforward analytically. Given the exploratory nature of these analyses, we simply chose to interpret associations relative to class A with largest membership that appeared to reflect normal maternal glucose response rather than perform pairwise comparisons for all classes.

Fifth, regarding Fig. 3 (1), we plotted lowess curves within estimated latent class groups to help confirm appropriateness of a quadratic shape for the available data. We acknowledge that plots of the estimated quadratic trajectories would also be informative.

Undoubtedly, maternal glucose response during an OGTT is more dynamic than captured by available HAPO data. Trajectory models were explored to complement analyses that emphasized individual associations of fasting, 1-h, and 2-h maternal glucose across the continuum with offspring metabolic outcomes. We agree that increased granularity of timed glucose measures in future studies would enhance physiological understanding and potential clinical utility of well-calibrated models of pregnancy OGTT data.

Article Information

Funding. The HAPO FUS is funded by grant 1U01DK094830 from the National Institute of Diabetes and Digestive and Kidney Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The HAPO Study was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD-34242 and R01-HD-34243). HAPO FUS data were collected and managed using REDCap electronic data capture tools hosted at Northwestern University Feinberg School of Medicine. REDCap is supported at the Northwestern University Feinberg School of Medicine by the Northwestern University Clinical and Translational Sciences Institute, which is supported by the National Institutes of Health’s National Center for Advancing Translational Sciences, grant UL1TR001422.

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

  • © 2019 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

References

  1. ↵
    1. Scholtens DM,
    2. Kuang A,
    3. Lowe LP, et al.; HAPO Follow-up Study Cooperative Research Group
    . Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): maternal glycemia and childhood glucose metabolism. Diabetes Care 2019;42:381–392
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Hulman A
    . Comment on Scholtens et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): maternal glycemia and childhood glucose metabolism. Diabetes Care 2019;42:381–392 (Letter). Diabetes Care 2019;42:e127. DOI: 10.2337/dc19-0650
    OpenUrlFREE Full Text
  3. ↵
    1. Hulman A,
    2. Witte DR,
    3. Vistisen D, et al
    . Pathophysiological characteristics underlying different glucose response curves: a latent class trajectory analysis from the prospective EGIR-RISC study. Diabetes Care 2018;41:1740–1748
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Nylund KL,
    2. Asparouhov T,
    3. Muthen BO
    . Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct Equ Modeling 2007;14:535–569
    OpenUrlCrossRefWeb of Science
  5. ↵
    1. Yang CC
    . Evaluating latent class analysis models in qualitative phenotype identification. Comput Stat Data Anal 2006;50:1090–1104
    OpenUrlCrossRefWeb of Science
PreviousNext
Back to top
Diabetes Care: 42 (7)

In this Issue

July 2019, 42(7)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Response to Comment on Scholtens et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism. Diabetes Care 2019;42:381–392
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Response to Comment on Scholtens et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism. Diabetes Care 2019;42:381–392
Denise M. Scholtens, Boyd E. Metzger
Diabetes Care Jul 2019, 42 (7) e128-e129; DOI: 10.2337/dci19-0024

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Response to Comment on Scholtens et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism. Diabetes Care 2019;42:381–392
Denise M. Scholtens, Boyd E. Metzger
Diabetes Care Jul 2019, 42 (7) e128-e129; DOI: 10.2337/dci19-0024
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Response to Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128–2136
  • Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128–2136
  • Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948–1957
Show more e-Letters: Comments and Responses

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.